Literature DB >> 14577481

Psycho-social well-being and general health status after surgical treatment for localized renal cell carcinoma.

Vincenzo Ficarra1, Giovanni Novella, Alessandra Sarti, Giacomo Novara, Antonio Galfano, Stefano Cavalleri, Walter Artibani.   

Abstract

OBJECTIVE: To comparatively assess the psychological, social well-being and general state of health in patients with stage 1 renal cell carcinoma (RCC) (according to 1997 TNM), who underwent either elective nephron sparing surgery (NSS) or radical nephrectomy. PATIENTS AND METHODS: We evaluated the health-related quality of life (HR-QoL) in 88 patients who underwent radical nephrectomy and in 56 treated with elective NSS. The measurement of the main QoL components has been made using domain-specific questionnaires tested and validated in Italian language. Each questionnaire has been self-administrated during follow-up (cross-sectional study).
RESULTS: The two analysed group resulted perfectly comparable regarding age, gender, civil status, educational level, profession and mean follow-up. A low level anxiety has been documented in 11.4% of patients after radical nephrectomy and in 1.8% of those treated with an elective conservative surgery. The mean score difference between the two groups resulted statistically significant (p = 0.003). A mild depression has been recorded in 7% of patients who underwent radical nephrectomy and in 2.3% of NSS group. The mean score difference between the two groups was statistically significant (p = 0.01). The general health status was impaired in 12.5% of cases after radical nephrectomy and in 7% after elective NSS. Social problems were present in 18% of patients who underwent radical nephrectomy and in 18% of NSS group. There was no significant difference between radical and conservative group in terms of both General health Questionnaire and Social Problem Questionnaire mean scores.
CONCLUSION: HR-QoL in patients who underwent surgery for RCC is not particularly negatively affected. Nevertheless, the comparative analysis of the results showed that, at a long term follow-up, radical surgery seems to eventually cause a more relevant negative impact on the psychological well-being than conservative surgery.

Entities:  

Mesh:

Year:  2002        PMID: 14577481     DOI: 10.1023/a:1025683306449

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  32 in total

Review 1.  Nephron sparing surgery for renal tumors: indications, techniques and outcomes.

Authors:  R G Uzzo; A C Novick
Journal:  J Urol       Date:  2001-07       Impact factor: 7.450

2.  The List of Threatening Experiences: a subset of 12 life event categories with considerable long-term contextual threat.

Authors:  T Brugha; P Bebbington; C Tennant; J Hurry
Journal:  Psychol Med       Date:  1985-02       Impact factor: 7.723

3.  Long-term results of simple and radical nephrectomy for renal cell carcinoma.

Authors:  J Ramon; B Goldwasser; G Raviv; P Jonas; M Many
Journal:  Cancer       Date:  1991-05-15       Impact factor: 6.860

4.  Quality of life of patients with renal cell carcinoma or prostate cancer after radical surgery.

Authors:  J Pannek; D Hallner; J Kugler; G Haupt; G M Krüskemper; T Senge
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

5.  Conservative surgery of renal cell tumors in 140 patients: 21 years of experience.

Authors:  F Steinbach; M Stöckle; S C Müller; J W Thüroff; S W Melchior; R Stein; R Hohenfellner
Journal:  J Urol       Date:  1992-07       Impact factor: 7.450

6.  Management of small solitary unilateral renal cell carcinomas: impact of central versus peripheral tumor location.

Authors:  K S Hafez; A C Novick; B P Butler
Journal:  J Urol       Date:  1998-04       Impact factor: 7.450

7.  Nephron sparing surgery in incidental versus suspected renal cell carcinoma.

Authors:  M R Licht; A C Novick; M Goormastic
Journal:  J Urol       Date:  1994-07       Impact factor: 7.450

8.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

9.  Treatment of renal cell carcinoma by in situ partial nephrectomy and extracorporeal operation with autotransplantation.

Authors:  H Zincke; D E Engen; K M Henning; M W McDonald
Journal:  Mayo Clin Proc       Date:  1985-10       Impact factor: 7.616

10.  Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.

Authors:  S E Lerner; C A Hawkins; M L Blute; A Grabner; P C Wollan; J T Eickholt; H Zincke
Journal:  J Urol       Date:  1996-06       Impact factor: 7.450

View more
  4 in total

1.  The kidney cancer research priority-setting partnership: Identifying the top 10 research priorities as defined by patients, caregivers, and expert clinicians.

Authors:  Jennifer Jones; Jaimin Bhatt; Jonathan Avery; Andreas Laupacis; Katherine Cowan; Naveen Basappa; Joan Basiuk; Christina Canil; Sohaib Al-Asaaed; Daniel Heng; Lori Wood; Dawn Stacey; Christian Kollmannsberger; Michael A S Jewett
Journal:  Can Urol Assoc J       Date:  2017-11-01       Impact factor: 1.862

2.  Disability, psychological distress and quality of life in relation to cancer diagnosis and cancer type: population-based Australian study of 22,505 cancer survivors and 244,000 people without cancer.

Authors:  Grace Joshy; Joanne Thandrayen; Bogda Koczwara; Phyllis Butow; Rebekah Laidsaar-Powell; Nicole Rankin; Karen Canfell; John Stubbs; Paul Grogan; Louise Bailey; Amelia Yazidjoglou; Emily Banks
Journal:  BMC Med       Date:  2020-12-01       Impact factor: 8.775

3.  Quality of life and complications after nephron-sparing treatment of renal cell carcinoma stage T1-a systematic review.

Authors:  Theresa Junker; Louise Duus; Benjamin S B Rasmussen; Nessn Azawi; Lars Lund; Ole Graumann; Birgitte Nørgaard
Journal:  Syst Rev       Date:  2022-01-04

4.  Comparison of baseline quality of life measures between renal cell carcinoma patients undergoing partial versus radical nephrectomy.

Authors:  Michelle L Arnold; David D Thiel; Nancy Diehl; Kevin J Wu; Steve Ames; Alexander S Parker
Journal:  BMC Urol       Date:  2013-10-22       Impact factor: 2.264

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.